How to appeal an Aetna interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Aetna-specific note: Owned by CVS Health since 2018. CVS Caremark is the PBM. Aetna ASA administers self-funded ERISA plans. Meritain Health is Aetna's TPA brand.

What Aetna's policy requires for interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty

Cited policy: Aetna CPB on Prostate Artery Embolization for BPH (historically labeled experimental — recently updating per AUA/SIR 2024 Position)

Symptomatic BPH (IPSS >=12, often >=18 for severe) refractory to >=6-12 mo medical therapy (alpha-blocker + 5-ARI), prostate volume >=40 mL on imaging, Qmax <=12 mL/s on uroflow, surgical contraindication or patient declines TURP / HoLEP / Aquablation.

How Aetna denies interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty — and how to counter it

Where Aetna pushes back: 1) PAE labeled 'experimental'; 2) TURP / HoLEP / surgery should be tried first; 3) Medical therapy log incomplete; 4) Prostate volume below threshold.

Counter-arguments that hold up: Cite AUA/SIR 2024 Position Statement endorsing PAE in selected patients. UK-ROPE registry (Ray BJU Int 2018). PARTEM RCT (Bilhim Eur Urol 2024) — PAE non-inferior to TURP for selected. AUA BPH Guideline acknowledges PAE as option. Document IPSS, Qmax, prostate volume on MRI / TRUS. Document medical therapy trial with dose / duration / response. For surgical contraindication / refusal, document anesthesia risk or patient preference.

What Aetna typically denies for interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty

Across Aetna's commercial and Medicare books, denials cluster around a small number of patterns. For interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty, expect:

• UM-2575 medical necessity denials
• Prior auth absent
• Step therapy on specialty drugs
• Out-of-network ER reduction

Treatments most often denied in this category

These are the interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty treatments most often flagged for prior auth, step therapy, or medical necessity review:

• UFE (uterine fibroid embolization)
• PAE (prostate artery embolization)
• TIPS
• Y-90 radioembolization
• TACE (HCC)
• Cryoablation

How to submit the appeal to Aetna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Aetna cited in the denial.
3. File the appeal through Aetna's portal (members: https://www.aetna.com ; providers: https://www.aetnaprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Aetna's prior-authorization criteria by drug: Aetna PA criteria on ApprovalHelp.